Jane N. Winter, MD, a highly regarded lymphoma expert, will serve as President of the American Society of Hematology (ASH) for a year-long term through December 2022.
Dr. Winter is Professor of Medicine in the Division of Hematology/Oncology, a member of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University’s Feinberg School of Medicine, and a hematologist at Northwestern Medicine. Dr. Winter’s research interests include clinical and biologic markers of prognosis in diffuse large B-cell lymphoma as well as clinical trials and translational research with novel agents in Hodgkin and non-Hodgkin lymphomas.
Jane N. Winter, MD
“Never before have there been so many promising scientific advances and new effective therapies in the field of hematology,” said Dr. Winter. “As ASH President, I look forward to facilitating collaboration among ASH members and others who share our mission globally. It is through this vital scientific exchange that we can learn, adapt, and, above all, improve care for those living with blood disorders. I am eager to welcome all who have an interest in hematology to the ASH family. I look forward to advancing our mission to promote research, high-quality equitable clinical care, education, training, and advocacy in hematology.”
Dr. Winter has been a member of ASH for 39 years; during that time, she has served in various leadership roles representing the Society, most recently serving as an ASH Councilor and a member of ASH’s Executive Committee. She was a member of the Committee on Educational Affairs (CEA) for 10 years, served as Education Program Co-Chair for the annual meeting, and was Vice-Chair and then Chair of the CEA.
